|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
51,320,000 |
Market
Cap: |
5.00(B) |
Last
Volume: |
262,995 |
Avg
Vol: |
492,576 |
52
Week Range: |
$71.24 - $95.38 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P SMALLCAP 600 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 438 |
Guru Rank Value : 3.1 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Haemonetics is a global healthcare company providing a suite of medical products and solutions for customers. Co.'s technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Co. has three principal reporting segments: Plasma, which provides automated plasma collection and donor management software systems; Blood Center, which provides a range of solutions that improve donor collection centers' ability to collect and filter blood and separate blood components; and Hospital, which has four product lines, including Hemostasis Management, Vascular Closure, Transfusion Management and Cell Salvage.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
2,305 |
2,305 |
24,823 |
94,111 |
Total Sell Value |
$218,975 |
$218,975 |
$2,201,702 |
$7,357,280 |
Total People Sold |
1 |
1 |
4 |
9 |
Total Sell Transactions |
1 |
1 |
7 |
34 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Scanlan Jacqueline |
SVP, Global Human Resources |
|
2019-06-17 |
4 |
OE |
$41.64 |
$120,340 |
D/D |
2,890 |
8,564 |
|
- |
|
Goldstein Dan |
VP, Corporate Controller |
|
2019-06-13 |
4 |
AS |
$110.58 |
$10,395 |
D/D |
(94) |
2,789 |
|
- |
|
Basil Michelle L |
EVP and General Counsel |
|
2019-06-12 |
4 |
S |
$109.37 |
$25,264 |
D/D |
(231) |
13,138 |
|
- |
|
Simon Christopher |
President & CEO |
|
2019-06-12 |
4 |
S |
$109.37 |
$136,494 |
D/D |
(1,248) |
246,151 |
|
- |
|
Burke Willaim P |
EVP, Chief Financial Officer |
|
2019-06-12 |
4 |
S |
$109.37 |
$20,780 |
D/D |
(190) |
14,460 |
|
- |
|
Bolorforosh Said |
EVP, Chief Technology Officer |
|
2019-06-12 |
4 |
S |
$109.37 |
$7,547 |
D/D |
(69) |
2,141 |
|
- |
|
Goldstein Dan |
VP, Corporate Controller |
|
2019-06-12 |
4 |
S |
$109.37 |
$4,265 |
D/D |
(39) |
2,883 |
|
- |
|
Scanlan Jacqueline |
SVP, Global Human Resources |
|
2019-06-12 |
4 |
S |
$109.37 |
$11,812 |
D/D |
(108) |
5,674 |
|
- |
|
Goldstein Dan |
VP, Corporate Controller |
|
2019-06-10 |
4 |
AS |
$104.38 |
$20,041 |
D/D |
(192) |
2,922 |
|
- |
|
Scanlan Jacqueline |
SVP, Global Human Resources |
|
2019-06-07 |
4 |
S |
$103.38 |
$21,503 |
D/D |
(208) |
5,782 |
|
- |
|
Goldstein Dan |
VP, Corporate Controller |
|
2019-06-07 |
4 |
AS |
$103.38 |
$8,064 |
D/D |
(78) |
3,114 |
|
- |
|
Simon Christopher |
President & CEO |
|
2019-06-07 |
4 |
S |
$103.38 |
$292,979 |
D/D |
(2,834) |
247,399 |
|
- |
|
Basil Michelle L |
EVP and General Counsel |
|
2019-06-07 |
4 |
AS |
$103.38 |
$743,801 |
D/D |
(7,187) |
13,369 |
|
- |
|
Basil Michelle L |
EVP and General Counsel |
|
2019-06-07 |
4 |
OE |
$38.43 |
$187,231 |
D/D |
4,872 |
20,556 |
|
- |
|
Burke Willaim P |
EVP, Chief Financial Officer |
|
2019-06-07 |
4 |
S |
$103.38 |
$42,489 |
D/D |
(411) |
14,650 |
|
- |
|
Goldstein Dan |
VP, Corporate Controller |
|
2019-06-06 |
4 |
AS |
$103.25 |
$114,298 |
D/D |
(1,107) |
3,192 |
|
- |
|
Goldstein Dan |
VP, Corporate Controller |
|
2019-06-06 |
4 |
OE |
$41.64 |
$46,095 |
D/D |
1,107 |
4,299 |
|
- |
|
Basil Michelle L |
EVP and General Counsel |
|
2019-06-06 |
4 |
AS |
$103.25 |
$634,781 |
D/D |
(6,148) |
15,684 |
|
- |
|
Basil Michelle L |
EVP and General Counsel |
|
2019-06-06 |
4 |
OE |
$41.64 |
$256,003 |
D/D |
6,148 |
21,832 |
|
- |
|
Simon Christopher |
President & CEO |
|
2019-05-23 |
4 |
S |
$99.39 |
$2,426,309 |
D/D |
(24,412) |
250,233 |
|
- |
|
Simon Christopher |
President & CEO |
|
2019-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
53,654 |
274,645 |
|
- |
|
Kroll Mark W |
Director |
|
2019-05-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,449 |
22,157 |
|
- |
|
Bolorforosh Said |
EVP, Chief Technology Officer |
|
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,275 |
2,210 |
|
- |
|
Llorens Josep |
SVP, Global Manufacturing |
|
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,530 |
2,871 |
|
- |
|
Goldstein Dan |
VP, Corporate Controller |
|
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
573 |
3,192 |
|
- |
|
1312 Records found
|
|
Page 12 of 53 |
|
|